Category: Biopharma
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates
USA News Group CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, May 23, 2024 — USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of...
Read MoreEarly Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment
USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, May 17, 2024 — USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test...
Read MoreBiotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, May 15, 2024 — USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently...
Read MoreBiotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
USA News Group CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, May 9, 2024 — In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted...
Read MoreTop Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032
USA News Group CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, May 3, 2024 — According to a “highly troubling” new study, the rising number of cancer cases in young people is being...
Read MoreBiotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
USA News Group Commentary Issued on behalf of BioVaxys Technology Corp. VANCOUVER, BC, May 1, 2024 — USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger...
Read More
AI in Healthcare: Unveiling the Future with a 42.20% CAGR Through 2029
USA News Group Commentary VANCOUVER, BC, April 25, 2024 /PRNewswire/ — Across several...
Read More
BioVaxys in Non-Binding Discussions for Major Immunotherapeutics Technology Acquisition
VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB)...
Read More